1086MO Lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients (pts) with advanced mucosal melanoma after progression on immune checkpoint inhibitors (ICI): Results from the phase II C-144-01 study

G-U. Grigoleit, H. Kluger, Sajeve Thomas, Jason Chesney, E. Domingo-Musibay, M.F. Sanmamed, Theresa Medina, Mirjana Ziemer, Eric D. Whitman, Friedrich Graf Finckenstein, Jeffrey Chou, Xiao Wu, G. Sulur, Wen Shi, Amod A. Sarnaik